Study of Bimatoprost Gel on Eyelash Growth

Completed · Phase 3

Conditions studied: Madarosis, Hypotrichosis

In brief

A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.

Key facts

Study ID

NCT01200251

Run by

Duke University

People needed

20

Starts

2007-02-01

Expected to finish

2008-12-01

Last updated by the study team

2014-07-16

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 18-80 YO females
• madarosis or hypotrichosis (loss of eyelashes) due to chemotherapy used to treat breast cancer
• only breast cancer patients

You may not qualify if…

• inability to follow up, apply gel
• active eye/eyelid infection or inflammatory process
• cancer not related to breast cancer, healthy patients
• males

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.